Clinical Trial: Page 2

AnchorDx enrolling U.S. clinical trial for bladder cancer assay
The study, which will enroll more than 1,000 participants, aims to evaluate the noninvasive, qPCR assay which detects two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer.
November 23, 2022
Bladder Urinary 3 D Social
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
Biological Dynamics said that it is collaborating with Qure Healthcare and Curta to also evaluate the effects of its pancreatic cancer detection assay on patient outcomes and healthcare economics.
November 23, 2022
Pancreatic Neuroendocrine Tumor Pnet Social
Roche points to results of heart failure study leveraging its cardiac hormone biomarker and test
The results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.
November 9, 2022
Cardiac Heart Eeg Social
SomaLogic touts NIH study of proteomic profiling platform
According to company, researchers conducting the study found that the platform demonstrates strength in proteome coverage and sensitivity, and it provides consistently low variability.
October 28, 2022
Protein Molecule
Glympse to present data on the detection of hepatocellular carcinoma with biosensor platform
In combination, the Glympse assay and a blood biomarker test demonstrated an area under the curve (AUC) of 0.90 in differentiating HCC and cirrhosis patients.
October 25, 2022
Liver Social
OpGen subsidiary Curetis collaborating with BioVersys on drug trial
The clinical trial will use Unyvero HPN with hospitalized pneumonia patients to determine eligibility for enrollment in the study.
October 25, 2022
Bacteria Microscope Social
Most Popular
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Quest Diagnostics offers suite of services for transplant patients and living donors
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
Serum protein in study predicted which patients might die without a liver transplant
Self-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrieval
Brigham and Women’s Hospital researchers are developing an algorithm to speed whole-slide-imaging retrieval from large digital repositories.
October 19, 2022
Artificial Intelligence Ai Hand
Prelude Dx to present clinical utility data for DCIS risk assessment test
DCISionRT predicts radiation therapy benefit through a risk assessment test for patients with ductal carcinoma in situ (DCIS).
October 21, 2022
Breast Cancer Social
Interpace Biosciences announces data for test to assess indeterminate thyroid nodules
The data support both versions of its test platform and a blinded analysis of pairwise miRNA expression profiling demonstrated greater accuracy than its original testing platform, the firm said.
October 21, 2022
Thyroid Social
Biofidelity developing assay for single-molecule detection of multiple gene fusions
The firm said its assay analyzes DNA and RNA concurrently from a single patient sample and can return results within two days.
October 18, 2022
Lung Cancer2 Social
Multicenter study highlights deficiencies in invasive lobular carcinoma assessment
The researchers emphasized that the study results, and the difficulties inherent in detecting ILC on mammograms, demonstrate the need for molecular tests specifically designed for ILC.
October 17, 2022
Breast Cancer Cell
GTC reports on validation of targeted transcriptome algorithms for diagnostic use
GTC’s RNAnalysis algorithm is used to distinguish between 45 different diagnostic classes, providing probability scores. The algorithm is complemented by a second one called TraceWork.
October 13, 2022
Artificial Intelligence Ai Data
Previous Page
Page 2 of 16
Next Page